[go: up one dir, main page]

AR054103A1 - Sales de amino de 1,2,3-triazoles, composiciones farmaceuticas que las contienen y usos como agentes antivirales - Google Patents

Sales de amino de 1,2,3-triazoles, composiciones farmaceuticas que las contienen y usos como agentes antivirales

Info

Publication number
AR054103A1
AR054103A1 ARP050105612A ARP050105612A AR054103A1 AR 054103 A1 AR054103 A1 AR 054103A1 AR P050105612 A ARP050105612 A AR P050105612A AR P050105612 A ARP050105612 A AR P050105612A AR 054103 A1 AR054103 A1 AR 054103A1
Authority
AR
Argentina
Prior art keywords
triazols
pharmaceutical compositions
compositions containing
antiviral agents
amino salts
Prior art date
Application number
ARP050105612A
Other languages
English (en)
Inventor
Alicia Regueiro-Ren
John F Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AR054103A1 publication Critical patent/AR054103A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicacion 1: Un compuesto de la formula (1), caracterizado porque incluye las sales farmacéuticamente aceptables del mismo, en donde: R1 es seleccionado del grupo que consiste de hidrogeno, halogeno y metoxi; -W- es seleccionado del grupo que consiste de la formula (2), en donde R4, R5, R6, R7, R8, R9, R10, R11 son cada uno independientemente H o metilo, con la condicion de que no más de dos sean metilo; R12 es seleccionado del grupo que consiste de C(O)-fenilo; e Y es halogeno, O(C)OCH3, OC(O)CF3, u otro contraion de la sal farmacéutica aceptable.
ARP050105612A 2004-12-29 2005-12-28 Sales de amino de 1,2,3-triazoles, composiciones farmaceuticas que las contienen y usos como agentes antivirales AR054103A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64018504P 2004-12-29 2004-12-29

Publications (1)

Publication Number Publication Date
AR054103A1 true AR054103A1 (es) 2007-06-06

Family

ID=36553758

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105612A AR054103A1 (es) 2004-12-29 2005-12-28 Sales de amino de 1,2,3-triazoles, composiciones farmaceuticas que las contienen y usos como agentes antivirales

Country Status (5)

Country Link
US (1) US7183284B2 (es)
AR (1) AR054103A1 (es)
PE (1) PE20060868A1 (es)
TW (1) TW200635925A (es)
WO (1) WO2006071564A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100209A1 (en) * 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) * 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
WO2012082746A2 (en) * 2010-12-13 2012-06-21 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CN105283455B (zh) * 2013-03-27 2017-06-16 百时美施贵宝公司 作为hiv吸附抑制剂的2‑酮基酰胺衍生物
WO2014160689A1 (en) * 2013-03-27 2014-10-02 Bristol-Myers Squibb Company Piperazine and homopiperazine derivatives as hiv attachment inhibitors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219892A (en) 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
KR940000112B1 (ko) 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US6469006B1 (en) 1999-06-15 2002-10-22 Bristol-Myers Squibb Company Antiviral indoleoxoacetyl piperazine derivatives
US6476034B2 (en) 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US20020061892A1 (en) 2000-02-22 2002-05-23 Tao Wang Antiviral azaindole derivatives
US6573262B2 (en) 2000-07-10 2003-06-03 Bristol-Myers Sqibb Company Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
US20030207910A1 (en) 2001-02-02 2003-11-06 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20040110785A1 (en) 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
KR20030079979A (ko) 2001-02-02 2003-10-10 브리스톨-마이어스스퀴브컴파니 치환된 아자인돌옥소아세틱 피페라진 유도체의 조성물 및항바이러스 활성
US6825201B2 (en) 2001-04-25 2004-11-30 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic amidopiperazine derivatives
US20030236277A1 (en) 2002-02-14 2003-12-25 Kadow John F. Indole, azaindole and related heterocyclic pyrrolidine derivatives
AU2003215469A1 (en) 2002-03-28 2003-10-13 Procyon Biopharma Inc. Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors
US7037913B2 (en) 2002-05-01 2006-05-02 Bristol-Myers Squibb Company Bicyclo 4.4.0 antiviral derivatives
US6900206B2 (en) 2002-06-20 2005-05-31 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives

Also Published As

Publication number Publication date
TW200635925A (en) 2006-10-16
WO2006071564A3 (en) 2007-04-12
US7183284B2 (en) 2007-02-27
US20060142298A1 (en) 2006-06-29
WO2006071564A2 (en) 2006-07-06
PE20060868A1 (es) 2006-08-23

Similar Documents

Publication Publication Date Title
ES2624795T3 (es) Derivados de N-(heteroaril)-1-heteroaril-1H-indol-2-carboxamidas, su preparación y su aplicación en terapéutica
AR053195A1 (es) Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo
HRP20090577T8 (en) Use of crth2 antagonist compounds in therapy
CO6341631A2 (es) Derivados de 1,2,4 - oxadiazol y su uso terapéutico
CR9459A (es) Derivados benzodioxano y benzodioxolano y usos de los mismos
AR078151A1 (es) Conjugados de acidos grasos y niacina, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades metabolicas.
SE0202463D0 (sv) Novel compounds
AR049739A1 (es) Derivados de aril-piridina
AR051755A1 (es) Compuestos biciclicos y triciclicos antagonistas del receptor cgrp
AR065772A1 (es) Compuestos de indolobenzazepina para el tratamiento de la hepatitis c. composiciones farmaceuticas.
UY29047A1 (es) Derivados de sulfonamidas, su preparación y su aplicación en terapéutica
AR054890A1 (es) Derivados de quinolina como agentes antibacterianos
TW200738607A (en) Sulfonamide derivatives, preparation thereof and therapeutic use thereof
AR055616A1 (es) Compuestos de tiofeno bencimidazol
AR107927A1 (es) Compuestos de pirrolidina, sal farmacéuticamente aceptable del mismo, composición farmacéutica que lo comprende y su uso para la fabricación de un medicamento
CO6351793A2 (es) \"derivados de indol macrociclicos utiles como inhibidores del virus de la hepatitis
UY28855A1 (es) Derivados de la 1-amino-ftalazina su preparación y su uso en terapia
UY29609A1 (es) Derivados de benzamidina y usos relacionados de los mismos
AR088320A1 (es) Derivados de isoindolinona y pirrolopiridinona como inhibidores de akt
ATE478054T1 (de) Benzimidazolderivate
UY27685A1 (es) Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso
ATE507212T1 (de) Morpholine als 5ht2c-agonisten
AR054103A1 (es) Sales de amino de 1,2,3-triazoles, composiciones farmaceuticas que las contienen y usos como agentes antivirales
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
AR054559A1 (es) Derivados de purina como inhibidores del receptor a2a de adenosina

Legal Events

Date Code Title Description
FB Suspension of granting procedure